Evaluation of combination therapy with Statin and Ezetimible for patients with type II diabetes.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 29 Jul 2015 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan.
- 28 Jan 2013 Planned End Date (31 Mar 2015) added as reported by University Hospital Medical Information Network - Japan.
- 03 Aug 2009 New trial record